TriangleNCT03252431 · OUTCOME
Duration in Days of Hospitalization
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- days
- Interval / dispersion
- Standard Deviation
- Time frame
- across all 4 chemotherapy cycles (average 84 days)
What was measured
The duration in days of patients been hospitalized for febrile neutropenia (FN) or any infection. Febrile neutropenia is defined as a single oral temperature of ≥38.3°C (101°F) or a temperature of \>38.0°C (100.4°F) sustained for \>1 hour and ANC \<0.5 x 10\^9/L on the same day.
Analysis population: ITT (Intent-to-Treat) population
Groups in this outcome
F-627
F-627, 20 mg fixed dose pre-filled syringe, administered on Day 2 of each of 4 chemotherapy cycles. F-627: single dose pre-filled syringe
Neulasta
6 mg fixed dose Neulasta®, administered on Day 2 of each of 4 chemotherapy cycles Neulasta: single dose pre-filled syringe
| Group | Source count |
|---|---|
| F-627 | 197 |
| Neulasta | 196 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| F-627 | 0.1 | 0.78 | Not reported | Not reported | Not reported |
| Neulasta | 0 | 0.57 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 0.78
- value
- 0.1
- group Id
- OG001
- spread
- 0.57
- value
- 0
- denoms
- counts
- group Id
- OG000
- value
- 197
- group Id
- OG001
- value
- 196
- units
- Participants
- description
- The duration in days of patients been hospitalized for febrile neutropenia (FN) or any infection. Febrile neutropenia is defined as a single oral temperature of ≥38.3°C (101°F) or a temperature of \>38.0°C (100.4°F) sustained for \>1 hour and ANC \<0.5 x 10\^9/L on the same day.
- dispersion Type
- Standard Deviation
- groups
- description
- F-627, 20 mg fixed dose pre-filled syringe, administered on Day 2 of each of 4 chemotherapy cycles. F-627: single dose pre-filled syringe
- id
- OG000
- title
- F-627
- description
- 6 mg fixed dose Neulasta®, administered on Day 2 of each of 4 chemotherapy cycles Neulasta: single dose pre-filled syringe
- id
- OG001
- title
- Neulasta
- param Type
- MEAN
- population Description
- ITT (Intent-to-Treat) population
- reporting Status
- POSTED
- time Frame
- across all 4 chemotherapy cycles (average 84 days)
- title
- Duration in Days of Hospitalization
- type
- SECONDARY
- unit Of Measure
- days
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice